Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06532253 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Long-term Safety Trial with NVDX3

Study acronym: X3LTFU
StatusRecruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Aug 1, 2024 to Aug 22, 2024
    • Study description expanded, about 32 words
    • Site details revised
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
An study evaluating the long-term safety of all patients previously treated with NVDX3.
Trial Details
NCT Number NCT06532253
Lead Sponsor Novadip Biosciences
Collaborators: PrimeVigilance, Data Investigation Company Europe (DICE)
Conditions
(from sponsor)		 Distal Radius Fractures, Degenerative Lumbar Spondylolisthesis
Related terms Wrist Fractures
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov